Related Experiment Video
Updated: Apr 26, 2026

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Published on: January 29, 2021
Eyelid myeloid sarcoma: ominous presentation of acute myelogenous leukemia
Paul O Phelps1, Marcus M Marcet, Augustine R Hong
1Department of Ophthalmology, John H. Stroger, Jr., Hospital of Cook County , Chicago, IL , USA and.
Abstract:
A 19 year-old African American man presented to our clinic for a second opinion about a right upper eyelid mass which had been recalcitrant to treatment for nonspecific orbital inflammation by an outside facility. Examination for systemic causes of the patients eyelid lesion led to a diagnosis of acute myelogenous leukemia (AML) FAB subtype M1. A subsequent biopsy of the eyelid tumor confirmed the diagnosis of a myeloid sarcoma. The patient succumbed to complications from his leukemia within 13 months of presentation. This case report is the first, to our knowledge, of an eyelid myeloid sarcoma as the presenting sign of AML and demonstrates the poor prognosis of this lesion.

